TOPICAL TREATMENT OF ATOPIC DERMATITIS IN CHILDREN: DIFFERENTIATED APPROACH



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article is devoted to mechanisms of atopic dermatitis, modern topical treatment and usefulness of topical emollients in children

Full Text

Restricted Access

About the authors

G I Smirnova

First Moscow State Medical University named after I. M. Setchenov

Email: smimov@nczd.ru
Russia

References

  1. Смирнова Г.И. Современная концепция лечения атопического дерматита. «ММА им. И.М. Сеченова». М., 2006, 132 с.
  2. DaVeiga S.P. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012, v. 33, p. 227-234.
  3. Scheinmann P, Pham Thi N., Karila C. et al. Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy. Arch. Pediatr. 2012, v. 19, p. 330-334.
  4. Van Beelen A.J., Teunissen M.B., Kapsenberg M.L. et al. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 2007, v. 7, p. 374-381.
  5. Raap U., Weißmantel S., Gehring M. et al. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr. Allergy Immunol. 2012, v. 23, p. 285-288.
  6. Savinko T, Matikainen S., Saarialho-Kere U. et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J. Invest. Dermatol. 2012, v. 132, p. 1392-1400.
  7. Kezic S., O’Regan G.M., Yau N. et al. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy. 2011, v. 66, p. 934-940.
  8. Kim B.E., Leung D.Y Epidermal barrier in atopic dermatitis. Allergy Asthma Immunol. Res. 2012, v. 4, p. 120-126.
  9. Kezic S., O’Regan G.M., Lutter R. et al. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency. J. Allergy Clin. Immunol. 2012, v. 129, p. 1031-1039.
  10. Mizutani Y., Mitsutake S., Tsuji K. et al. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie. 2009, v. 91, p. 784-790.
  11. Cornelissen C., Marquardt Y., Czaja K. et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models J. Allergy Clin. Immunol. 2012, v. 129, p. 426-433.
  12. Burks A.W., Tang M., Sicherer S. et al. ICON: food allergy. J. Allergy Clin. Immunol. 2012, v. 129, p. 906-920.
  13. Bergstrom K.G. Truth or fiction: risk factors for childhood atopic dermatitis. J. Drugs Dermatol. 2012, v. 11, p. 126-128.
  14. Novak N. New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy. 2009, v. 64, p. 265-275.
  15. Daehnhardt-Pfeiffer S., Surber C., Wilhelm K.P et al. Noninvasive stratum corneum sampling and electron microscopical examination of skin barrier integrity: pilot study with a topical glycerin formulation for atopic dermatitis. Skin Pharmacol. Physiol. 2012, v. 25, p. 155-161.
  16. Смирнова Г.И. Эмольянты в наружной терапии атопического дерматита у детей. Рос. педиатр. журн. 2011, № 4, c. 37-42.
  17. Kircik L.H., Del Rosso J.Q. Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J. Clin. Aesthet. Dermatol. 2011, v. 4, p. 25-31.
  18. Koga C., Kabashima K., Shiraishi N. et al. Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 2008, v. 128, p. 2625-2630.
  19. Hon K.L., Wang S.S., Wong W.L. et al. Skin prick testing in atopic eczema: atopic to what and at what age? World J. Pediatr. 2012, v. 8, p. 164-168.
  20. Ring J., Alomar A., Bieber T et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part I. J. Eur. Acad. Dermatol. Venereol. 2012, v. 26, p. 1045-1060.
  21. Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part II. J. Eur. Acad. Dermatol. Venereol. 2012, v. 26, p. 1176-1193.
  22. Yin Z.Q., Zhang W.M., Song G.X. et al. Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis. J. Dermatol. 2012, v. 39, p. 520-526.
  23. Shi V.Y., Tran K., Lio P.A. A comparison of physicochemical properties of a selection of modern moisturizers: hydrophilic index and pH. J. Drugs Dermatol. 2012, v. 11, p. 633-636.
  24. Verdier-Sévrain S., Bonté F. Skin hydration: a review on its molecular mechanisms. J. Cosmet. Dermatol. 2007, v. 6, p. 75-82.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2012



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies